Blue Water Vaccines, Inc.
NASDAQ: BWV0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Neil J. Campbell MA, MBA
- Employees
- 12
- Headquarters
- Cincinnati, United States
- IPO year
- 2022
- Market cap
- $3.4M
- Website
- https://www.bluewatervaccines.com
Loading BWV…
Loading profile data…Frequently asked questions about BWV
What does Blue Water Vaccines, Inc. (BWV) do?
Blue Water Vaccines, Inc. (BWV) operates as a biotechnology firm dedicated to the worldwide discovery and development of vaccines aimed at preventing infectious diseases. Currently in preclinical stages, their most prominent vaccine candidates are BWV-101, an influenza shot, and BWV-102, designed to counter H1 pre-pandemic threats. The company's...
Where does BWV trade?
Blue Water Vaccines, Inc. (BWV) trades on the NASDAQ Capital Market.
What sector is BWV in?
Blue Water Vaccines, Inc. (BWV) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Blue Water Vaccines, Inc.?
Neil J. Campbell MA, MBA is the chief executive officer of Blue Water Vaccines, Inc. (BWV).
Where is Blue Water Vaccines, Inc. headquartered?
Blue Water Vaccines, Inc. is headquartered in United States.
Does BWV pay a dividend?
Blue Water Vaccines, Inc. (BWV) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BWV go public?
Blue Water Vaccines, Inc. (BWV) completed its initial public offering in 2022.